Correlation Between Eliem Therapeutics and Petros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Petros Pharmaceuticals, you can compare the effects of market volatilities on Eliem Therapeutics and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Petros Pharmaceuticals.
Diversification Opportunities for Eliem Therapeutics and Petros Pharmaceuticals
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eliem and Petros is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Petros Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Petros Pharmaceuticals
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Petros Pharmaceuticals. In addition to that, Eliem Therapeutics is 1.13 times more volatile than Petros Pharmaceuticals. It trades about -0.38 of its total potential returns per unit of risk. Petros Pharmaceuticals is currently generating about -0.27 per unit of volatility. If you would invest 36.00 in Petros Pharmaceuticals on August 25, 2024 and sell it today you would lose (9.00) from holding Petros Pharmaceuticals or give up 25.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Eliem Therapeutics vs. Petros Pharmaceuticals
Performance |
| Timeline |
| Eliem Therapeutics |
| Petros Pharmaceuticals |
Eliem Therapeutics and Petros Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Petros Pharmaceuticals
The main advantage of trading using opposite Eliem Therapeutics and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Petros Pharmaceuticals vs. Eliem Therapeutics | Petros Pharmaceuticals vs. HCW Biologics | Petros Pharmaceuticals vs. RenovoRx | Petros Pharmaceuticals vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |